These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 20445429)

  • 21. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's Disease and other disorders.
    Raja M; Bentivoglio AR
    Curr Drug Saf; 2012 Feb; 7(1):63-75. PubMed ID: 22663960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
    Eusebio A; Witjas T; Cohen J; Fluchère F; Jouve E; Régis J; Azulay JP
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):868-74. PubMed ID: 23447648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine agonists and therapy compliance.
    Grosset D
    Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field.
    Ambermoon P; Carter A; Hall WD; Dissanayaka NN; O'Sullivan JD
    Addiction; 2011 Feb; 106(2):283-93. PubMed ID: 21134016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
    Voon V; Potenza MN; Thomsen T
    Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

  • 28. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.
    Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS
    Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features associated with impulse control disorders in Parkinson disease.
    Pontone G; Williams JR; Bassett SS; Marsh L
    Neurology; 2006 Oct; 67(7):1258-61. PubMed ID: 17030761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impulse control disorders in Parkinson's disease.
    Vilas D; Pont-Sunyer C; Tolosa E
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S80-4. PubMed ID: 22166463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
    Voon V; Hassan K; Zurowski M; de Souza M; Thomsen T; Fox S; Lang AE; Miyasaki J
    Neurology; 2006 Oct; 67(7):1254-7. PubMed ID: 16957130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
    Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
    Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant development of hypersexuality and delusional jealousy in patients with Parkinson's disease: a case series.
    Poletti M; Lucetti C; Baldacci F; Del Dotto P; Bonuccelli U
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1290-2. PubMed ID: 25277963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
    Ceravolo R; Frosini D; Rossi C; Bonuccelli U
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological gambling in Parkinson's disease.
    Stocchi F
    Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
    Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
    Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.